Apellis Pharmaceuticals

apellis.com

Apellis Pharmaceuticals is a biotechnology company focused on complement science, developing innovative therapies for debilitating diseases, particularly in ophthalmology and rare diseases. With two product approvals in less than two years, they aim to transform treatment options for patients suffering from conditions driven by complement activation. Their commitment to patient advocacy and community engagement sets them apart in the industry, positioning them as a leader in complement therapeutics with a robust pipeline of clinical trials and research initiatives.